North America Companion Diagnostics Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The North America Companion Diagnostics Devices Market is Segmented by Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Other Technologies), Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma, and Other Indications) and Geography. The report offers the value (in USD million) for the above segments.

North America Companion Diagnostics Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

North America Companion Diagnostics Devices Industry Overview

The North American companion diagnostics devices market is highly competitive due to the presence of a large number of players. Some of the key companies in the market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux SA, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens Healthcare, and Thermo Fisher Scientific Inc., among others.

North America Companion Diagnostics Devices Market Leaders

  1. Abbott

  2. F. Hoffmann-La Roche Ltd

  3. Biomerieux SA

  4. Qiagen NV

  5. Agilent Technologies Inc.

  6. *Disclaimer: Major Players sorted in no particular order
North America Companion Diagnostics Devices Market Concentration

North America Companion Diagnostics Devices Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?